Add Yahoo as a preferred source to see more of our stories on Google. It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes ...

Please provide your email address to receive an email when new articles are posted on . Arcutis Biotherapeutics announced in a press release that only around one in four patients with seborrheic ...

Seborrheic dermatitis can be a stubborn condition to treat, but lifestyle changes, home remedies, and over-the-counter products, including certain shampoos and conditioners, can all be helpful, ...

This article was reviewed by Knox Beasley, MD. Flakes on your scalp making you feel self-conscious? Let's talk about seborrheic dermatitis vs dandruff. Whether your scalp feels like a snowglobe thanks ...

New York — Seborrheic dermatitis (SD) is a common and shared disorder across populations, but it is the third most common dermatologic complaint that Black individuals bring to the dermatologist and ...

WESTLAKE VILLAGE, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...

After 8 weeks, eight out of ten people with seborrheic dermatitis saw their symptoms cleared or improved with once-daily treatment with roflumilast 0.3% foam, according to the results of the phase 3 ...

Please provide your email address to receive an email when new articles are posted on . This decision makes Zoryve the first drug approved in this indication with a new mechanism of action in more ...

Credit: Arcutis. Zoryve topical foam is a once-daily steroid-free formulation of a highly potent and selective phosphodiesterase type 4 inhibitor. The Food and Drug Administration (FDA) has approved ...